Today: 21 May 2026
Builders FirstSource stock jumps 12% as Trump’s mortgage-bond push rewires the housing trade
12 January 2026
2 mins read

Builders FirstSource stock jumps 12% as Trump’s mortgage-bond push rewires the housing trade

New York, Jan 11, 2026, 21:03 EST — Market closed

  • Builders FirstSource (BLDR) closed Friday up about 12% at $124.66
  • Housing-linked stocks rallied after Trump ordered $200 billion in mortgage-bond purchases
  • Tuesday’s U.S. CPI report is the next big test for rates and the housing tape

Builders FirstSource Inc (BLDR) shares closed up about 12% on Friday, snapping the stock back into the center of the rate-sensitive housing trade. The stock ended at $124.66, up $13.37 from Thursday’s close.

The company sells structural building products and components to homebuilders and remodelers, a business that can speed up or stall with mortgage rates. Builders FirstSource calls itself the nation’s largest supplier of structural building products and value‑added components for residential construction and repair work.

Now it’s a timing game. Investors will be watching whether cheaper mortgages turn into more orders, not just a one-day squeeze.

President Donald Trump ordered $200 billion in mortgage-backed securities purchases — bonds backed by home loans — in a bid to push down mortgage rates; Federal Housing Finance Agency Director Bill Pulte said Fannie Mae and Freddie Mac will execute the buying. Analysts at TD Cowen said the move could narrow the gap between the 30-year mortgage and the 10-year Treasury, which lenders watch when setting rates. “Every little bit will help,” Annex Wealth Management’s Brian Jacobsen told Reuters, while warning that stimulating demand does not fix housing supply. Reuters

Mortgage spreads — the extra yield lenders demand over Treasuries — tightened by more than 20 basis points overnight, HousingWire’s Logan Mohtashami wrote, helping push 30-year rates below 6% even as the 10-year yield moved little. He said spreads have been abnormally wide in recent years, and a shift back toward “normal” levels can pull mortgage rates down without a big bond rally. HousingWire

Redfin said the daily average 30-year fixed mortgage rate fell to 5.99% on Jan. 9 from 6.21% a day earlier, the lowest level in nearly three years. “This may be near the lowest” mortgage rates fall for the foreseeable future, Redfin economics head Chen Zhao said. Redfin

Housing data released the same day were mixed. The Census Bureau said October housing starts ran at a 1.246 million-unit seasonally adjusted annual rate, down 4.6% from September, while single-family starts rose 5.4% to 874,000; permits slipped 0.2% to 1.412 million.

The Friday move was broad across housing and building-products names. Boise Cascade rose about 6%, TopBuild gained about 6%, and D.R. Horton added nearly 8%, based on market data.

Rate hopes also leaned on a softer jobs report: U.S. payrolls rose 50,000 in December and the unemployment rate slipped to 4.4%, Reuters reported. Fitch Ratings’ Olu Sonola said job growth was “stuck in stall speed,” even as the unemployment rate should cool the Fed’s urgency to respond to weakening labor data. Reuters

But the setup is fragile. If inflation surprises on the upside and pushes Treasury yields higher, mortgage rates could rebound quickly and take the air out of Friday’s rally; and Trump’s bond-buying plan still has execution and political risk written all over it.

Monday’s open will show whether Builders FirstSource can hold the gains once the headline trade meets fresh positioning.

The next hard timestamp is Tuesday’s U.S. consumer price index report for December, due at 8:30 a.m. ET, a release that often swings bond yields — and, by extension, housing-linked stocks like BLDR.

Stock Market Today

  • Asian Shares Rise on Oil Price Drop and Nvidia's Strong AI-Driven Earnings
    May 21, 2026, 1:31 AM EDT. Asian shares surged Thursday, led by South Korea's Kospi gaining 8%, following Wall Street's AI-driven rally and easing bond market pressure. Nvidia's quarterly profit jumped over 200%, fueled by demand for its AI chips, boosting tech stocks like Samsung Electronics, which rose 7.5%, and SK Hynix, up 11.3%. Taiwan's Taiex added 3.9%, supported by TSMC's 3% increase. Japan's Nikkei climbed 3.6% aided by a 15% rise in exports. Oil prices fell sharply, with Brent down 5%, arousing hopes of renewed U.S.-Iran oil supply talks, before a partial rebound. U.S. stocks also recovered, with the S&P 500 up 1.1% as 10-year Treasury yields eased, reducing pressure on equities amid inflation and interest rate concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Woodside Energy Group Ltd stock rises on ASX as oil firms; traders eye Jan 28 report
Previous Story

Woodside Energy Group Ltd stock rises on ASX as oil firms; traders eye Jan 28 report

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 12.01.2026

Go toTop